Calcium hydroxyapatite injection may correct orbital volume deficit with post enucleation socket syndrome: Study

• Patients demonstrated a mean increase in orbital volume of 3.35 ± 0.91 at 6 months and 2.97 ± 1.35 at 10 years post-injection.

• The mean follow-up duration was 219 ± 18 months, with clinical and cosmetic improvement observed to persist for 10 years.

• Complications were minimal, including peribulbar ecchymosis, two cases of extrusions of the internal prosthesis, and two cases of ptosis.

• The study highlights the long-term efficacy and safety of injectable CAHY for correcting orbital volume deficit in post enucleation socket syndrome.

• The sustained improvement observed over 10 years, along with minimal complications, underscores the reliability of this technique.

Injectable CAHY emerges as a safe, simple, and cost-effective option for treating orbital volume deficiency in post enucleation socket syndrome. Its semi permanent nature and negligible volume loss over 10 years make it a promising solution for patients seeking lasting cosmetic improvement. Further research and larger studies are warranted to validate these findings and optimise treatment protocols.

Reference:

Di Maria, A., Ferraro, V., Trenti, N., Morenghi, E., Gaeta, A., Vinciguerra, P., & Confalonieri, F. Ten-year follow-up of orbital volume augmentation with calcium hydroxyapatite filler in postenucleation socket syndrome. Ophthalmic Plastic and Reconstructive Surgery,2024;40(1):49–54. https://doi.org/10.1097/iop.0000000000002500